Achim Berthele (A Berthele)

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 10

Top Topics

Mass Spectrometry

Spectrum Disorder

Multiple Sclerosis

Top Venues

Neurology(R) neuroimmunology & neuroinflammation

International journal of molecular sciences

Scientific reports

ImmunoTargets and therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Dominic Bertram, Thanos Tsaktanis, Achim Berthele, Thomas Korn
The role of intrathecal free light chains kappa for the detection of autoimmune encephalitis in subacute onset neuropsychiatric syndromes. Scientific reports 13 (1) (2023)
Katrin Giglhuber, Achim Berthele
Adverse Events in NMOSD Therapy. International journal of molecular sciences 23 (8) (2022)
Martin W Hümmert, Louisa M Schöppe, Judith Bellmann-Strobl, Nadja Siebert, Friedemann Paul, Ankelien Duchow, Hannah Pellkofer, Tania Kümpfel, Joachim Havla, Sven Jarius, Brigitte Wildemann, Achim Berthele, Florian Then Bergh, Marc Pawlitzki, Luisa Klotz, Ingo Kleiter, Martin Stangel, Stefan Gingele, Martin S Weber, Juergen H Faiss, Refik Pul, Annette Walter, Uwe K Zettl, Makbule Senel, Jan-Patrick Stellmann, Vivien Häußler, Kerstin Hellwig, Ilya Ayzenberg, Orhan Aktas, Marius Ringelstein, Olivia Schreiber-Katz, Corinna Trebst, null null
Costs and Health-Related Quality of Life in Patients With NMO Spectrum Disorders and MOG-Antibody-Associated Disease: CHANCE NMO Study. Neurology 98 (11) (2022)
Markus Lauerer, Matthias Bussas, Viola Pongratz, Achim Berthele, Jan Stefan Kirschke, Benedikt Wiestler, Claus Zimmer, Bernhard Hemmer, Mark Mühlau
Percentage brain volume change in multiple sclerosis mainly reflects white matter and cortical volume. Annals of clinical and translational neurology (2022)
Lilian Aly, Christina Noll, Rebecca Wicklein, Elisabeth Wolf, Eva Feodora Romahn, Josphine Wauschkuhn, Sami Hosari, Christian Mardin, Achim Berthele, Bernhard Hemmer, Thomas Korn, Benjamin Knier
Dynamics of Retinal Vessel Loss After Acute Optic Neuritis in Patients With Relapsing Multiple Sclerosis. Neurology(R) neuroimmunology & neuroinflammation 9 (3) (2022)
Marius Ringelstein, Ilya Ayzenberg, Gero Lindenblatt, Katinka Fischer, Anna Gahlen, Giovanni Novi, Helen Hayward-Könnecke, Sven Schippling, Paulus S Rommer, Barbara Kornek, Tobias Zrzavy, Damien Biotti, Jonathan Ciron, Bertrand Audoin, Achim Berthele, Katrin Giglhuber, Helene Zephir, Tania Kümpfel, Robert Berger, Joachim Röther, Vivien Häußler, Jan-Patrick Stellmann, Daniel Whittam, Anu Jacob, Markus Kraemer, Antoine Gueguen, Romain Deschamps, Antonios Bayas, Martin W Hümmert, Corinna Trebst, Axel Haarmann, Sven Jarius, Brigitte Wildemann, Matthias Grothe, Nadja Siebert, Klemens Ruprecht, Friedemann Paul, Nicolas Collongues, Romain Marignier, Michael Levy, Michael Karenfort, Michael Deppe, Philipp Albrecht, Kerstin Hellwig, Ralf Gold, Hans-Peter Hartung, Sven G Meuth, Ingo Kleiter, Orhan Aktas, null null
Interleukin-6 Receptor Blockade in Treatment-Refractory MOG-IgG-Associated Disease and Neuromyelitis Optica Spectrum Disorders. Neurology(R) neuroimmunology & neuroinflammation 9 (1) (2021)
Friederike Held, Ana-Katharina Klein, Achim Berthele
Drug Treatment of Neuromyelitis Optica Spectrum Disorders: Out with the Old, in with the New? ImmunoTargets and therapy 10 (2021)
A Bayas, Achim Berthele, B Hemmer, C Warnke, B Wildemann
Controversy on the treatment of multiple sclerosis and related disorders: positional statement of the expert panel in charge of the 2021 DGN Guideline on diagnosis and treatment of multiple sclerosis, neuromyelitis optica spectrum diseases and MOG-IgG-associated disorders. Neurological research and practice 3 (1) (2021)
Bernhard Michalke, Achim Berthele, Vivek Venkataramani
Simultaneous Quantification and Speciation of Trace Metals in Paired Serum and CSF Samples by Size Exclusion Chromatography-Inductively Coupled Plasma-Dynamic Reaction Cell-Mass Spectrometry (SEC-DRC-ICP-MS). International journal of molecular sciences 22 (16) (2021)
Katrin Giglhuber, Achim Berthele
Eculizumab in the treatment of neuromyelitis optica spectrum disorder. Immunotherapy 12 (14) (2020)